1–10 of 62 results for PDR
Association Between DRSS Changes and Visual/ Anatomic Outcomes in Patients With Moderately Severe to Severe NPDR: Post Hoc Analysis of PANORAMA
Diana V Do, MD, FASRS
Annual Meeting Talks
2022
ASRS Updates in the Management of Diabetic Retinopathy DME and PDR in the Middle East and Africa
Sunir J. Garg, MD, FACS, FASRS
Webinars and Journal Clubs
2023
A Nightmare on PDR-TRD Street
On Demand Cases, Courses, and Papers
High risk Proliferative Diabetic Retinopathy treated with Pan Retinal Photocoagulation
Somnath Chakraborty, MD
Retina Image Bank: Images of the Week
Impact of Intravitreal Anti-VEGF Therapy for Severe Non-Proliferative Diabetic Retinopathy (NPDR): Analyses Through a Monte-Carlo Simulation Model
Andrew A. Moshfeghi, MD, MBA, FASRS
2021
Aflibercept Versus Vitrectomy With Panretinal Photocoagulation for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Hani Salehi-Had, MD
Amine Oxidase Copper-Containing 3 Inhibitor (BI 1467335) in Non-Proliferative Diabetic Retinopathy: Double-Masked, Randomized, Phase IIa Study (ROBIN)
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Automated Macular Vessel Density Quantification of Fluorescein Angiograms Among PDR Patients: Positive Correlation With Vision
Ajay E Kuriyan, MD, MS
2020
Outcomes of Treatment-naïve Eyes With Proliferative Diabetic Retinopathy Treated With Navigated Laser (NAVILAS) Pan-retinal Photocoagulation
Pradeep Satya Prasad, MD, MBA
JXT and Proliferative Diabetic Retinopathy
Abhishek Verma